Table 12.9b

Unadjusted Graft Survival, Living Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 28 78.6% 7.8% 28 78.6% 7.8% 71 60.5% 6.3% 129 41.2% 5.5%
Primary Diagnosis Cystic Fibrosis 22 86.4% 7.3% 22 86.4% 7.3% 58 56.1% 7.3% 108 40.9% 5.6%
Idiopathic Pulmonary Fibrosis 2 50.0% 35.4% 2 50.0% 35.4% 5 80.0% 17.9% 5 + +
Primary Pulmonary Hypertension 1 100.0% 0.0% 1 100.0% 0.0% 2 100.0% 0.0% 3 + +
Congenital Disease 0 - - 0 - - 0 - - 3 33.3% 27.2%
Other 3 33.3% 27.2% 3 33.3% 27.2% 6 66.7% 19.2% 10 50.0% 15.8%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.